跳至主要内容
临床试验/IRCT201207283305N4
IRCT201207283305N4已完成2 期

Comparison the effect of paracetamol and pethedine in reducing opioid consumption and pain scale in patients under gastrointestinal tract malignancies surgery.

Vice-chancellor of Research Babol University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • ASA class I-III; patient whom candidates GI Malignancy surgery and are hospitalized in ICU ward after surgery.
  • Exclusion criteria: A History of sensitivity to paracetamol; kidney disease (end stage); liver disease or more than two times increase in the liver enzymes; severe malnutrition or dehydration; alcohol users; Recipients Recipients probensid, Salyslamyd or drugs that are induce liver enzymes.Severe drop in blood pressure during or after, severe dyspnea requiring respiratory support, severe thrombocytopenia, decreased level of consciousness.

排除标准

  • 未提供

研究者

发起方
Vice-chancellor of Research Babol University of Medical Sciences

相似试验